NUS
Nu Skin Enterprises, Inc.
Set alert
- YTD
- -51.66%
- 1 year
- -56.21%
- Open
- 4.71
- Prev close
- 4.69
- Mkt cap
- 226.35M
- Vol
- 351.49K
- Avg vol
- 526.88K
- EPS
- -4.51
- P/E
- 0.00
- Div yield
- 3.64%
More statistics
- Low
- 4.63
- High
- 4.80
- Forward P/E
- 6.47
- Beta
- 1.13
- Short ratio
- 1.83
- Inst. own
- 81.02%
- Dividend
- 0.24
- Ex-div date
- Nov 28, 2024
- Earnings
- Feb 12, 2025
- 50-d avg
- 6.96
- 200-d avg
- 9.95
- 1y target
- 6.92
Key statistics
- Market cap
- 334.56M
- Enterprise value
- 614.80M
- Trailing P/E
- 0.00
- Forward P/E
- 6.47
- PEG ratio
- 0.00
- Price / sales
- 0.19
- Price / book
- 0.47
- EPS (TTM)
- -2.09
- Beta
- 1.13
- Dividend yield
- 3.64%
- Payout ratio
- 917.65%
- Profit margin
- -5.81%
- Revenue (TTM)
- 1.78B
- Revenue growth
- -13.80%
- Free cash flow
- 131.05M
- Total cash
- 244.09M
- Total debt
- 530.80M
- Return on equity
- -13.50%
- Shares outstanding
- 49.71M
- Short % of float
- 4.67%
- 50-day average
- 6.96
- 200-day average
- 9.95
Analyst view
Consensus: hold
- Target (low)
- 6.75
- Target (mean)
- 6.92
- Target (high)
- 7.00
- Strong buy0
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate 0.24582.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 0.21 | — | — | — |
| Nov 7, 2024 | Sep 1, 2024 | 0.20 | 0.17 | -0.03 | -15.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.18 | 0.21 | +0.03 | +16.67% |
| May 8, 2024 | Mar 1, 2024 | 0.05 | 0.09 | +0.04 | +80.00% |
| Feb 14, 2024 | Dec 1, 2023 | 0.29 | 0.37 | +0.08 | +27.59% |
| Nov 1, 2023 | Sep 1, 2023 | 0.64 | 0.56 | -0.08 | -12.50% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 22, 2024 | Citigroup | main | Neutral | Neutral |
| Aug 12, 2024 | DA Davidson | main | Neutral | Neutral |
| Aug 9, 2024 | Citigroup | main | Neutral | Neutral |
| May 9, 2024 | DA Davidson | main | Neutral | Neutral |
| Jan 5, 2024 | DA Davidson | main | Neutral | Neutral |
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- nuskin.com
News
- Nu Skin Enterprises to Announce Third Quarter 2026 Financial Results
- Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push
- STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore
- Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26
- Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
- Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
- Nu Skin Enterprises Q2 Earnings Call Highlights
- Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
Your note
Sign in to keep a note on NUS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATTLE EMMA S. | Director | Stock Award(Grant) | Jun 6, 2024 | 19,223 |
| CAMPBELL DANIEL W | Director | Stock Award(Grant) | Jun 6, 2024 | 117,030 |
| CLARK CHAYCE DAVID | General Counsel | Stock Award(Grant) | Feb 26, 2024 | 158,175 |
| LIPMAN ANDREW D | Director | Sale | May 27, 2024 | 23,225 |
| NATHANSON LAURA | Director | Stock Award(Grant) | Jun 6, 2024 | 21,630 |
| SHEN ZHEQING | Director | Stock Award(Grant) | Jun 6, 2024 | 33,195 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 10.27% | 5,104,656 | 34.35M | Sep 29, 2024 |
| Blackrock Inc. | 9.24% | 4,592,141 | 30.91M | Sep 29, 2024 |
| Shaw D.E. & Co., Inc. | 4.06% | 2,020,057 | 13.59M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 3.69% | 1,832,196 | 12.33M | Sep 29, 2024 |
| Millennium Management Llc | 2.61% | 1,296,590 | 8.73M | Sep 29, 2024 |
| State Street Corporation | 2.51% | 1,245,677 | 8.38M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Pacer Small Cap U.S. Cash Cows 100 ETF | 4.77% | 2,373,503 | 15.97M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 3.28% | 1,631,724 | 10.98M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.69% | 1,335,112 | 8.99M | Oct 30, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 2.35% | 1,166,788 | 7.85M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.63% | 809,977 | 5.45M | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.29% | 641,656 | 4.32M | Aug 30, 2024 |